Christopher Moen
Director, National Accounts at Pharmaessentia
Based in Minneapolis, United States
7-day free trial · no credit card
Seniority
Director
Department
Sales & Business Development
Location
Minneapolis
Industry
Biotechnology Research
Company size
338
Contact information
Reveal Christopher's email and phone
Direct contact data is gated. Sign up and reveal. You only pay for verified records.
c•••••••@pharmaessentia.com
Phone
5 credits+1 ••• •••• ••••
You only pay for valid records. Bounced emails and disconnected numbers cost nothing.
Background
About Christopher Moen
Managed Market & Payer Executive adept at cultivating profitable partnerships with key clientele and stakeholders to close high-stakes deals and expand product portfolios throughout the pharmaceutical ecosystem. Extensive experience directing complex change implementations and managing multidisciplinary teams to drive revenue growth and expand market share on a national scale, successfully positioning organizations as robust industry competitors. Results-oriented market access leader with a proven record of devising turnaround strategies to streamline processes and transform team members into million-dollar revenue generators. Areas of Expertise: Managed Markets Payer Strategy & Management Relationship Building Revenue Generation & Growth Senior Team Leadership Channel Strategy Trend Analysis & Forecasts Procurement Strategy Change Implementation Strategy Alignment Public Speaking Turnaround Strategy Select Accomplishments: • Led Quarterly Business Reviews (QBRs) with Channel Partners, communicating key performance indicators (KPIs) of distributor and pharmacies to both internal and external stakeholders in order to effectively safeguard partner performance, gap identification, and timely issue resolution. • Managed all procurement of pharmaceuticals equating to over $400M generics and $3B brand annually, providing comprehensive directions to two mail order sites and one specialty pharmacy to ensure efficiency and accuracy in all operations. • Successfully pioneered the Omnitrope exclusive agreement negotiation in 2008, ultimately delivering major savings to clients for an essential pharmaceutical. • Upheld market perception of the drug and therapeutics class by strategically maintaining and increasing access to Opsumit after generic competition entered the market in the PAH drug class.
Decision-makers
Other people at Pharmaessentia
- JMOther
Jason Mitch
' & · Other
- JNOther
James Nero
Sr Director Commercial Effectiveness and Training · Other
- PLManager
Peggy Loh
General Manager · Operations
- LGDirector
Lloyd Goldstein
Area Business Director South · Sales & Business Development
- LCStaff
Leon Chuang
Production Planning Engineer · Manufacturing & Production
Build a list of verified contacts at Pharmaessentia
Free for 7 days · 50 credits · no card · only pay for verified records.
Reach more buyers like Christopher
250M+ professionals with verified email and phone. You only pay for records that actually verify.
7-day trial · no credit card · cancel anytime